Ronan Sugrue

ORCID: 0000-0001-9379-5540
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pregnancy and preeclampsia studies
  • Maternal and fetal healthcare
  • Cardiovascular Issues in Pregnancy
  • Pregnancy and Medication Impact
  • Venous Thromboembolism Diagnosis and Management
  • Blood groups and transfusion
  • Preterm Birth and Chorioamnionitis
  • Maternal and Perinatal Health Interventions
  • Birth, Development, and Health
  • Cardiac, Anesthesia and Surgical Outcomes
  • Endometrial and Cervical Cancer Treatments
  • Neonatal Respiratory Health Research
  • Neonatal Health and Biochemistry
  • Ovarian cancer diagnosis and treatment
  • Erythrocyte Function and Pathophysiology
  • Ectopic Pregnancy Diagnosis and Management
  • Acute Myocardial Infarction Research
  • Mechanical Circulatory Support Devices
  • Hepatitis B Virus Studies
  • Economic and Financial Impacts of Cancer
  • Prenatal Substance Exposure Effects
  • Cancer Risks and Factors
  • Bariatric Surgery and Outcomes
  • Surgical Sutures and Adhesives
  • Cancer, Stress, Anesthesia, and Immune Response

National Maternity Hospital
2024

Duke University
2022-2024

Duke Medical Center
2021-2023

National Center for Advancing Translational Sciences
2022

National Institutes of Health
2022

Novo Nordisk (Switzerland)
2022

Brigham and Women's Hospital
2018-2022

Boston Children's Hospital
2021

Harvard University
2018-2020

Massachusetts General Hospital
2019-2020

Abstract Hemolytic disease of fetus and newborn (HDFN) is a life-threatening mediated by maternal alloimmunization to red blood cell (RBC) antigens. Studies prevalence in the United States lack national data. This study describes trends pregnancy States. RBC antibodies (abs) were identified large, nationwide, commercial laboratory database from 2010 through 2021. The cohort comprised pregnancies for which year collection patient’s state residence available. Data normalized based on US...

10.1182/bloodadvances.2023012241 article EN cc-by-nc-nd Blood Advances 2024-04-25

To evaluate the effects of eliminating routine use oral opioids for postcesarean delivery analgesia on opioid consumption.At a tertiary care center, we implemented quality improvement intervention among faculty practice patients undergoing cesarean delivery, which consisted 1) ordering after 2) implementing guidelines short course when deemed necessary, and 3) coupling prescribing at discharge to patterns in-hospital combined with shared decision-making. All patients, both before...

10.1097/aog.0000000000003010 article EN Obstetrics and Gynecology 2018-12-06

Objective The use of extracorporeal membrane oxygenation (ECMO) therapy has increased in the adult population. Studies from H1N1 influenza pandemic suggest that ECMO deployment pregnancy is associated with favorable outcomes. With increasing numbers pregnant women affected by COVID-19 (coronavirus disease 2019) and potentially requiring this life-saving therapy, we sought to compare comorbidities, costs, outcomes between pregnancy- nonpregnancy-associated among reproductive-aged female...

10.1055/a-2008-8462 article EN American Journal of Perinatology 2023-01-06

Previable premature prelabor rupture of membranes (pPPROM) can lead to significant maternal and neonatal morbidity mortality. Limited literature exists describing long-term outcomes in neonates surviving pPPROM. Our study describes 2-year survival after expectantly managed pPPROM at a single, tertiary, academic center. This is retrospective review including individuals with defined as membrane before 240/7 weeks who were candidates opted for expectant management single tertiary center...

10.1055/a-2405-3609 article EN American Journal of Perinatology 2024-09-27

Abstract Introduction GNAS mutations have been reported in both McCune-Albright syndrome (MAS) and juvenile granulosa cell tumors (JGCT) but never simultaneously the same patient. Case Presentation A 15-year-old girl developed secondary oligomenorrhea. Laboratory studies revealed suppressed gonadotropin levels with markedly elevated estradiol inhibin B levels. Pelvic ultrasound showed a 12-cm heterogeneous right adnexal mass; pelvic magnetic resonance imaging to further characterize mass...

10.1210/jendso/bvab098 article EN cc-by-nc-nd Journal of the Endocrine Society 2021-07-08
Coming Soon ...